On Sunday, Dr. Randall Williams, director of the Missouri Department of Health and Senior Services, signed the standing order for Janssen Biotech, Inc. Covid-19 vaccine administration after the review of recommendations made by the Centers for Disease Control and Prevention, according to a news release.
Janssen’s single-dose Covid-19 vaccine was authorized for emergency use on Saturday, February 27. This is the third vaccine authorized for use in the United States, with 50,000 doses of the vaccine expected in Missouri this week.
After results from a study conducted in South Africa, the vaccine was found to be 85% effective in preventing severe cases of Covid-19 delays after 28 days.
Reported side effects include pain or redness/swelling at the injection site, tiredness, headache, muscle pain, nausea and fever. Those who should not get the Janssen COVID-19 vaccine are those under age 18 and those who have had a severe allergic reaction to any ingredient of the vaccine